+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Acthar"

Acthar Gel - API Insight, 2022 - Product Thumbnail Image

Acthar Gel - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Acthar Gel- Drug Insight, 2019 - Product Thumbnail Image

Acthar Gel- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

Acthar is a brand of corticotropin, a hormone produced by the pituitary gland. It is used to treat a variety of conditions, including some infectious diseases. Acthar is approved by the U.S. Food and Drug Administration (FDA) for the treatment of infantile spasms, multiple sclerosis relapses, and nephrotic syndrome. It is also used off-label to treat a variety of other conditions, including some infectious diseases. Acthar is a specialty drug, meaning it is expensive and requires special handling. It is typically administered as an injection, and is available in both vial and pre-filled syringe forms. The Acthar market is highly competitive, with several companies offering their own versions of the drug. These include Mallinckrodt Pharmaceuticals, Questcor Pharmaceuticals, and Novartis Pharmaceuticals. Other companies, such as Mylan Pharmaceuticals and Teva Pharmaceuticals, offer generic versions of Acthar. Show Less Read more